Acute generalized exanthematous pustulosis due to sulfamethoxazol with positive lymphocyte transformation test (LTT)

Journal of Investigational Allergology and Clinical Immunology

Volumn 13, Issue 1, 2003, Pages 66-68

  Anliker, Mark David ^a   Wüthrich, Brunello ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

AGEP; Allergy; Co trimoxazol; Drug; Lymphocyte transformation test (LTT); Pustulosis; Sulfamethoxazol

Indexed keywords

BETAMETHASONE; COTRIMOXAZOLE; SULFAMETHOXAZOLE;

ADULT; ARTICLE; CASE REPORT; COOMBS TEST; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTE TRANSFORMATION TEST; NEPHROLITHIASIS; PUSTULOSIS; RASH; SKIN BIOPSY; SKIN TEST;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; DRUG ERUPTIONS; EXANTHEMA; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; SKIN TESTS; SULFAMETHOXAZOLE; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VASCULITIS, HYPERSENSITIVITY;

EID: 0037789385     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Feind-Koopmans, A., van der Valk, P.G.M., Steijlen, P.M., Van de Kerkhof, P.C. Toxic pustuloderma associated with clemastine therapy. Clin Exp Dermatol 1996, 21:293-295.
2. Tebbe, B., Treudler, R., Orfanos, C.E. Acute generalized exanthematous pustulosisis, induced by nystatin. Hautarzt 1998, 49:492-495.
3. Aquilina, C., Viraben, R., Rouiere, A. Acute generalized exanthematous pustulosisis. A cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor. Arch Intern Med 1998, 158:2160-2161.
4. Darvey, A., Basarab, T., Russell-Jones, R. Thalidomide-induced toxic pustuloderma. Clin Exp Dermatol 1997, 22:297-299.
5. Nyfeler, B., Pichler, W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997, 27:175-181.
6. Rustin, M.H.A., Robinson, T.W.E., Dowd, P.M. Toxic pustuloderma: a self-limiting eruption. Br J Dermatol 1990, 123:119-124.
7. Roujeau, J.C., Bioulac-Sage, P., Bourseau, C., Guillaume, J.C., Bernard, P., Lok, C., Plantin, P., Claudy, A., Delavierre, C., Vaillant, L., Wechsler, J., Danan, G., Bénichou, C., Beylot, C. Acute generalized exanthematous pustulosisis. Analysis of 63 cases. Arch Dermatol 1991, 127:1333-1338.
8. Braun-Falco, O., Luderschmidt, C., Maciejewski, W. et al. Generalized acute pustulosis. An unusual presentation of leukocytoclastic vasculitis. Hautarzt 1978, 29:371-377.
9. Bissonette, R., Tousignant, J., Allaire, G. Drug-induced toxic pustuloderma. Int J Dermatol 1992, 31:172-174.
10. Spencer, J.M., Silvers, D.N., Grossman, M.E. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption. Br J Dermatol 1992, 130:514-519.
11. MacDonald, K.J.S., Green, C.M., Kenicer, K.J.A. Pustular dermatosis induced by co-trimoxazol. Br Med J 1986, 293:1279-1280.
12. Schöpf, E. Skin reactions to co-trimoxazol. Infection 1987, 15(Suppl. 5P):254-258.
13. Menke, A. Arzneiexanthem unter dem Bilde der Pustulosis acuta generalisata bei Allergie auf Cotrimoxazol. Z Hautkr 1986, 61:1816.
14. Guy, C., Bonafe, J.L., Massip, P. Pustulose exanthématique géneralisée. Nouv Dermatol 1990, 9:540-543.
15. Knudson, L., Weisman, K. Pustular eruption and damage to internal organs following sulfamethoxazol-trimetoprim. Ugeskr Laegger 1977, 139:1007-1009.
16. Trüeb, R.M., Burg, G. Acute generalized exanthematous pustulosis due to doxycycline. Dermatology 1993, 186:75-78.
17. Katagiri, K., Takayasu, S. Drug induced acute generalized exanthematous pustulosis. J Dermatol 1996, 23:623-627.
18. Ballmer-Weber, B.K., Widmer, M., Burg, G. Acetylsalicysäure-induzierte generalisierte Pustulose. Schweiz Med Wochenschr 1993, 123:542-546.
19. Rogalski, C., Hürlimann, A., Burg, G., Wüthrich, B., Kempf, W. Terbinafine-induced acute generalized exanthematous pustulosis. Hautarzt 2001, 52:444-448.
20. Britschgi, M., Steiner, U.C., Schmid, S., Depta, J.P.H., Senti, G., Bircher, A., Burkhardt, C., Yawalkar, N., Pichler, W.J. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001, 107:1433-1441.
21. Wolkenstein, P., Chosidow, O., Fléchet, M.L., Robbiola, O., Paul, M., Dumé, L., Revuz, J., Roujeau, J.C. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996, 35:234-236.
22. Hari, Y., Frutig-Schnyder, K., Hurni, M., Yawalkar, N., Zanni, M.P., Schnyder, B., Kappeler, A., Von Greyerz, S., Braathen, L.R., Pichler, W.J. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001, 31:1398-1408.
23. Luque, I., Leyva, L., Torres, M.J., Rosal, M., Mayorga, C., Segura, J.M., Blanca, M., Juarez, C. In vitro T-cell responses to b-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001, 56:611-618.
24. Cederbrant, K., Marcusson-Stahl, M., Hultman, P. Characterization of primary recall in vitro lymphocyte responses to bacampillicin in allergic subjects. Clin Exp Allergy 2000, 30:1450-1459.
25. Burrows, N.P., Russel-Jones, R. Pustular drug eruptions: a histological spectrum. Histopathology 1993, 22:569-573.
26. Baggiolini, M., Walz, A., Kunkel, S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophiles. J Clin Invest 1989, 84:287-292.